Imaging for early stage breast cancer

Ongoing and future projects

(1) RTOG/NCI Phase II trial protocol : • Re-irradiation with EBRT •

Eligible pts.: Unicentric LR ≤ 3 cm, no skin involvement, clear margins, 0-3 + LNs • Accrual goal: 61 pts. • Primary end-point: ≥ G3 side effects occuring within 1 year

(2) GEC-ESTRO Breast Cancer WG : • Re-irradiation with multi-catheter HDR/PDR BT • Multicentric retrospective match-paired analysis has been finalized. • Results will come 12/2018

University Hospital Erlangen